Company / Operating Income
Oruka Therapeutics, Inc. Operating Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$88.1M
FY2024
5-year range
-$88.1M / -$5.8M
FY2020-FY2024
Trend
-1107.8%
vs FY2023
Sector context
#86 of 204
Health Care
What the data says
Operating Income changed -1108% YoY in FY2024, a notable deviation from the 9-year average annual change of -134%.
Based on SEC 10-K filings.
-$88M in FY2024.
Declined from -$19M to -$88M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 204 in Health CareTop 42% of 204This company -$88.1M Sector average $107.8M
▼
-181.8% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 1107.8% year-over-year.
- Ranks #86 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$88.1M | -1107.8% |
| FY2023 | -$7.3M | +62.3% |
| FY2022 | -$19.3M | -98.0% |
| FY2021 | -$9.8M | -68.0% |
| FY2020 | -$5.8M | +28.4% |
| FY2019 | -$8.1M | +56.6% |
| FY2018 | -$18.7M | -12.6% |
| FY2017 | -$16.6M | -45.0% |
| FY2016 | -$11.5M | -18.2% |
| FY2015 | -$9.7M | -39.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026